Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2026-02-11 @ 9:10 PM
Study NCT ID:
NCT02356458
Status:
TERMINATED
Last Update Posted:
2022-03-11
First Post:
2015-02-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of Ibrutinib and Bortezomib to Treat Patients With Mantle Cell Lymphoma
Sponsor:
Organization:
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
Enrollment Type:
Design Primary Purpose:
Design Masking:
Time Perspective List:
Who Masked List: